MedPath

Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers

Not Applicable
Recruiting
Conditions
Advanced Malignant Solid Neoplasm
Registration Number
NCT04870788
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

This clinical trial develops effective and appropriate mindfulness-based interventions that help meet the needs of Latino cancer patients and their family caregivers. Mindfulness-based interventions focus on building awareness of thoughts, emotions/feelings, and the sensations. This study may help improve mental well-being and reduce stress and anxiety associated with having cancer or with a family member's cancer diagnosis.

Detailed Description

PRIMARY OBJECTIVES:

I. Systematically and culturally adapt a mindfulness-based intervention to improve psychological wellbeing in Latino patients with advanced cancer and their family caregivers.

II. Evaluate the feasibility of the adapted mindfulness-based intervention and overall study procedures in Latino patient-family caregiver dyads.

SECONDARY OBJECTIVE:

I. Determine the effects of the adapted mindfulness-based intervention on the secondary outcomes of patient and caregiver psychological distress, quality of life (QOL), and patient cancer symptoms, compared to a waitlist control.

OUTLINE: Patients and their partners are randomized to 1 of 32 groups.

GROUP I: Patients and their partners participate in mindfulness program together over 60 minutes consisting of meeting with a mindfulness coach to build awareness of thoughts, emotions, feelings, and sensations 1 time per week (QW) for 4 weeks.

GROUP II: Patients and their partners participate in mindfulness program separately over 60 minutes consisting of meeting with a mindfulness coach to build awareness of thoughts, emotions, feelings, and sensations 1 time per week (QW) for 4 weeks.

GROUP III: Patients and their partners participate in mindfulness program either separately or together, depending on participants' preferences, as in Group I beginning 12 weeks after starting the study and completing the third study visit.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosed with a stage III-IV solid tumor
  • On active treatment
  • Self-identify as Hispanic/Latino
  • ECOG (Eastern Cooperative Oncology Group) performance status of =< 2
  • Willing to participate in the study with a family caregiver (e.g., spouse, adult child) with whom they currently reside and who consents to participate
Exclusion Criteria
  • At least 18 years old
  • Able to speak English or Spanish
  • Have access to the internet
  • Able to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Overall accrualUp to 12 weeks

Will calculate means, frequencies, and 90% confidence intervals (CIs), as applicable.

AdherenceUp to 12 weeks

Will calculate means, frequencies, and 90% CIs, as applicable.

AcceptabilityUp to 12 weeks

Will calculate means, frequencies, and 90% CIs, as applicable.

AttritionUp to 12 weeks

Will calculate means, frequencies, and 90% CIs, as applicable.

Secondary Outcome Measures
NameTimeMethod
Patient and caregiver psychological distressAt 6 and 12 weeks

Will examine means, standard deviations (SDs), and distributions of survey measures for ceiling/floor effects and restrictions in range and examine change over time.

Quality of life questionnaireAt 6 and 12 weeks

Will examine means, SDs, and distributions of survey measures for ceiling/floor effects and restrictions in range and examine change over time.

Patient cancer symptomsAt 6 and 12 weeks

Will examine means, SDs, and distributions of survey measures for ceiling/floor effects and restrictions in range and examine change over time.

Trial Locations

Locations (1)

M D Anderson Cancer Center

🇺🇸

Houston, Texas, United States

M D Anderson Cancer Center
🇺🇸Houston, Texas, United States
Larkin Strong
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.